ENvue® Feeding Tube Placement System Identified as Core Growth Platform Strategic Rebranding and Name Change to Reflect Company’s Focus on Multi-Billion-Dollar Enteral-Feeding...
Training platform accelerates onboarding, expands distribution potential and better positions Company for growth
NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced that it has entered into a definitive...
Latest patent award strengthens competitive moat and reinforces leadership in medical navigation technology
Patent strengthens company’s leadership in feeding tube placement and opens path to broader vascular navigation market
Common Stock Will Begin Trading on Split-Adjusted Basis on August 12, 2025
Upfront $8 Million in Gross Proceeds and potential $40 million in Gross Proceeds from Exercise of Additional Investment Rights
NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield ® , PainShield ® and WoundShield ® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today...
NanoVibronix, Inc ., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (“SAW”) technology, today announced...
NanoVibronix, Inc ., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (“SAW”) technology, today announced...